Royal Philips has announced it has received 510(k) clearance from the FDA to market ProxiDiagnost N90, its newest premium Digital Radiography-Fluoroscopy (DRF) system. With its ability to perform both nearby fluoroscopy and digital X-rays through a single system, ProxiDiagnost N90 supports high room utilisation and increased patient throughput, while also providing outstanding workflow support and patient accessibility.
Benefits of the new system for both patients and staff include:
“As a dual-use system, ProxiDiagnost N90 meets key dimensions of healthcare’s Quadruple Aim and is a smart choice for healthcare organisations that need a new fluoroscopy solution – particularly those in the U.S. that follow a nearby use method,” said Sandra Burghardt, Senior Director of Global Marketing for Diagnostic X-ray at Philips.
“We are setting the bar higher and enabling a confident diagnosis from the first frame. ProxiDiagnost N90 gives radiologists and technologists the ability to capture high-quality still or video images in a way that aligns with their workflow and provides an improved patient experience.”